Literature DB >> 23445739

Fatal community-acquired pneumonia: 18 years in a medical center.

Ling-Jen Wang1, Shu-Chi Mu, Cheng-Hui Lin, Ming-I Lin, Tseng-Chen Sung.   

Abstract

BACKGROUND: Community-acquired pneumonia (CAP) remains a significant cause of childhood morbidity worldwide. We analyzed the etiologies and the clinical characteristics of children who died from CAP. This study aimed at early identification of the poor prognostic factors in order to improve the efficiency of pneumonia management and prevent deaths.
METHODS: A retrospective chart review was performed for children younger than 18 years admitted to Shin Kong Wu Ho-Su Memorial Hospital between September 1992 and August 2010 with a diagnosis of pneumonia on admission. Twenty-one patients who died with the diagnosis of pneumonia and its complications were included in the study, along with 63 age- and year-matched survival controls.
RESULTS: Twelve patients (57.1%) were younger than 2 years. Gram-negative bacteria (7 patients) were the most frequently identified pathogen, followed by Mycoplasma pneumoniae (6 patients). Four of these six M. pneumoniae infected patients were co-infected with other pathogens. Among the clinical characteristics, fatal CAP was associated mainly with initial presentations of anemia, lymphopenia, thrombocytopenia, bandemia, hyponatremia, sepsis, meningitis, metabolic acidosis, disseminated intravenous coagulopathy, and underlying congenital diseases. In multivariate logistic regression analysis, metabolic acidosis (odds ratio = 8.50; 95% confidence interval = 2.82-25.60; p < 0.001) was a prognostic risk factor for fatality.
CONCLUSION: For patients with CAP, blood gas should be included in the routine blood test on admission. Once the initial blood test associated with the aforementioned poor prognostic factors has been identified, an immediate treatment including Gram-negative bacilli antibiotics should be started aggressively in order to prevent deaths.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2013        PMID: 23445739     DOI: 10.1016/j.pedneo.2012.11.003

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


  2 in total

1.  Validation of a B-type natriuretic peptide as a prognostic marker in pneumonia patients: a prospective cohort study.

Authors:  Daisuke Usuda; Ryusho Sangen; Yu Hashimoto; Emiri Muranaka; Yoshitsugu Iinuma; Tsugiyasu Kanda
Journal:  BMJ Open       Date:  2016-02-23       Impact factor: 2.692

2.  Risk factors for a poor outcome among children admitted with clinically severe pneumonia to a university hospital in Rabat, Morocco.

Authors:  Imane Jroundi; Chafiq Mahraoui; Rachid Benmessaoud; Cinta Moraleda; Houssain Tligui; Myriam Seffar; Salma Ech-Cherif El Kettani; Badr Sououd Benjelloun; Saad Chaacho; Carmen Muñoz-Almagro; Joaquim Ruiz; Pedro L Alonso; Quique Bassat
Journal:  Int J Infect Dis       Date:  2014-10-08       Impact factor: 3.623

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.